GLP-1 Misinformation Is Straining Primary Care

Erica Lamberg

October 27, 2026

The rapid growth of GLP-1s has transformed weight management, putting primary care physicians (PCPs) on the front lines of obesity care. Against this backdrop, a new GLP-1 provider strain survey conducted by Tebra, which surveyed 374 healthcare providers who prescribe or manage GLP-1 therapies, explores these key issues and shows that rising demand has created a substantial operational burden.

Providers must now correct viral misinformation and manage unrealistic patient expectations within standard consultation windows, making social media myths a routine, near-daily challenge.

According to the report, 73% of clinicians correct GLP-1 misinformation at least once a week, whereas 20% do so daily. The leading sources of misinformation were:

·         TikTok, cited by 59% of providers

·         Word of mouth from friends and family: 54%

·         Traditional news outlets: 21%

·         AI chatbots: 19%

In addition, 55% of clinicians say patient expectations about the speed and amount of weight loss are unrealistic to some degree.

Providers also spend an average of 8.7 h/wk on GLP-1 administrative duties. More than a third (35%) say medication demand directly contributes to professional burnout, and 20% have considered reducing their clinical hours, switching specialties, or leaving practice altogether.

Taken together, these findings underscore the clinical and operational challenges facing primary care. Here we will explore the issues at hand, including their implications for patient communication, clinical capacity, and outcomes.

The Daily Impact of Digital Misinformation

Social media often shapes what patients expect before they enter the exam room. When online posts promise easy weight loss or promote unproven dosing, PCPs must spend valuable appointment time correcting the record. Responses will vary from provider to provider. Some physicians quickly cut through the noise with clear data, whereas others use patients’ interest as a starting point for broader conversations about metabolic health.

Risks of Unmonitored Online Prescriptions

Beyond social media chatter, the rapid expansion of direct-to-consumer (DTC) digital prescribing platforms and unverified compounding outlets has introduced significant safety hazards into primary care practice. Many patients get GLP-1 prescriptions online after answering a short questionnaire, often without thorough testing or follow-up.

A 2026 research letter published in JAMA evaluated online prescribing platforms for GLP-1s, demonstrating that the vast majority of audited DTC services prescribed medications with minimal clinician oversight and frequently fulfilled orders through compounding pharmacies operating outside standard regulatory pathways.

When patients encounter unmanaged side effects, rapid weight regain, or dosing confusion from online vendors, they frequently present to primary care clinics for urgent management.

Setting Realistic Expectations in Your Practice

Referencing the survey, 55% of providers reported patients expect weight loss too quickly, so clear counseling from the start matters. Many patients see GLP-1s as a stand-alone fix and overlook the role of healthy eating, adequate protein, and resistance exercise. A 2025 study in The New England Journal of Medicine found that lasting benefits and muscle preservation also depend on ongoing lifestyle changes. The message for patients: GLP-1s work alongside healthy habits, not instead of them, experts stated.

That is why regular check-ins matter: They help providers adjust the dose, protect muscle, and keep patients safe when progress slows.

“I let patients know that if I’m prescribing a GLP-1 medication for them, I want to see them once a month, at a minimum, while we titrate the dose,” said Malchuk.

In addition, reframing consultations around personalized health drivers rather than arbitrary scale numbers helps build sustained patient commitment and prevents premature treatment discontinuation.

“Before starting a GLP-1, I work with patients to understand their goals and, more importantly, why those goals matter to them,” said Richardson.

Streamlining Workflows and Practice Structure

Practices are adapting based on the Tebra research as 31% have added staff, changed workflows, or both. And with 76% of providers seeing more interest in oral GLP-1s, 33% expect the pills to add, not reduce, administrative work because of dosing requirements, variable absorption, and insurance hurdles. Strong patient relationships can help keep these conversations focused and manageable.

“With a strong relationship, we use a shared decision-making process, but patients know that I have their best interest in mind, and that I have done the research and memorization of data,” said Scala.

Clear messaging streamlined intake and referrals to dietitians and exercise specialists can help PCPs manage demand without sacrificing care.

Systemic Challenges and the Future of Obesity Care

GLP-1 care also comes with bigger system hurdles. Prior authorizations, shifting insurance coverage, and supply shortages take up clinicians’ time and add to burnout. Even so, PCPs say these medications can have a major impact when patients receive proper medical guidance.